Gilead Sciences, Inc. P/E Ratio 2007–2025
Gilead Sciences, Inc. reported 17.88 of price-to-earnings ratio for fiscal 2025. That was 92.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -96.2%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 17.88 | -92.3% |
| FY 2024 | 233.60 | +1305.5% |
| FY 2023 | 16.62 | -20.7% |
| FY 2022 | 20.97 | +67.4% |
| FY 2021 | 12.52 | -97.4% |
| FY 2020 | 475.00 | +3837.2% |
| FY 2019 | 12.06 | +6.6% |
| FY 2018 | 11.32 | -24.2% |
| FY 2017 | 14.93 | +191.6% |
| FY 2016 | 5.12 | -13.2% |
| FY 2015 | 5.90 | -33.0% |
| FY 2014 | 8.80 | -69.1% |
| FY 2013 | 28.48 | +85.3% |
| FY 2012 | 15.37 | +93.7% |
| FY 2011 | 7.94 | +5.9% |
| FY 2010 | 7.49 | -28.9% |
| FY 2009 | 10.53 | -38.2% |
| FY 2008 | 17.04 | -11.5% |
| FY 2007 | 19.25 | — |
Source: Gilead Sciences, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open GILD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Gilead Sciences, Inc. reported 17.88 of price-to-earnings ratio for fiscal 2025. That was 92.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -96.2%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Gilead Sciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGilead Sciences, Inc. — frequently asked questions
What is Gilead Sciences, Inc.'s price-to-earnings ratio?
Gilead Sciences, Inc. (GILD) reported price-to-earnings ratio of 17.88 for fiscal year 2025, per its SEC filings.
How has Gilead Sciences, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, GILD's price-to-earnings ratio declined at roughly 0.4% per year (compound annual rate), from 19.25 to 17.88.
Where does this data come from?
Figures are computed from Gilead Sciences, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More GILD financial history
Full GILD fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →